Karsan, Nazia http://orcid.org/0000-0002-6946-5637
Goadsby, Peter J. http://orcid.org/0000-0003-3260-5904
Article History
Accepted: 10 August 2022
First Online: 29 August 2022
Declarations
:
: No specific funding was granted for the preparation and publication of this manuscript. Open access was funded by King’s College London.
: NK has no relevant financial disclosures to report. PJG reports, over the last 36 months, grants and personal fees from Eli-Lilly and Company; a grant from Celgene; personal fees from Aeon Biopharma, Allergan/Abbvie, Biohaven Pharmaceuticals Inc., CoolTech LLC, Dr Reddys, Epalex, Impel Neuropharma, Lundbeck, Novartis, Praxis, Sanofi, Satsuma and Teva Pharmaceuticals; personal fees for advice through Gerson Lehrman Group, Guidepoint, SAI Med Partners, Vector Metric; fees for educational materials from CME Outfitters, Omnia Education, WebMD; publishing royalties or fees from Massachusetts Medical Society, Oxford University Press, UptoDate and Wolters Kluwer; and for medicolegal advice in headache: and a patent magnetic stimulation for headache (No. WO2016090333 A1) assigned to eNeura without fee.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Data sharing is not applicable to this article as no datasets were generated or analysed during the current study.
: NK reviewed the literature and was responsible for drafting the manuscript, including producing the tables. PJG provided expert review and proofread the manuscript prior to submission for publication.